<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04668261</url>
  </required_header>
  <id_info>
    <org_study_id>2020-02314</org_study_id>
    <nct_id>NCT04668261</nct_id>
  </id_info>
  <brief_title>Longitudinal Investigation of Brain Blood Flow Changes in Neurosurgical Patients</brief_title>
  <official_title>Longitudinal Investigation of Brain Blood Flow Changes in Neurosurgical Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Zurich</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Zurich</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Primary study objective:&#xD;
&#xD;
      • Longitudinal observation of brain blood flow changes in neurosurgical patients with or&#xD;
      without a neurosurgical intervention as compared to a healthy cohort.&#xD;
&#xD;
      Secondary study objectives:&#xD;
&#xD;
        -  Longitudinal observation of hemodynamic patterns versus structural brain tissue changes&#xD;
           in neurosurgical patients.&#xD;
&#xD;
        -  Changes in blood flow patterns and structural brain tissue after neurosurgical&#xD;
           interventions as compared to a healthy cohort.&#xD;
&#xD;
        -  Determining hemodynamic imaging patterns that can be tested as novel imaging markers.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Primary study objective:&#xD;
&#xD;
      • to study the longitudinal observation of brain blood flow changes in neurosurgical patients&#xD;
      to evaluate the effect of surgical or conservative treatment on the brain structural and&#xD;
      hemodynamic integrity.&#xD;
&#xD;
      Secondary study objectives:&#xD;
&#xD;
        -  To observe the relationship between longitudinal changes in hemodynamic patterns and&#xD;
           structural brain tissue changes in neurosurgical patients.&#xD;
&#xD;
        -  To determine different hemodynamic patterns that may be used as novel imaging biomarkers&#xD;
           in future studies.&#xD;
&#xD;
      4.2 Outcomes&#xD;
&#xD;
      Outcomes of the project:&#xD;
&#xD;
      Primary endpoint:&#xD;
&#xD;
      To find correlation between course of disease, neurosurgical intervention and changes in&#xD;
      brain blood flow and brain structure.&#xD;
&#xD;
      Secondary endpoints:&#xD;
&#xD;
        -  Correlation between progression of disease and hemodynamic patterns over time (ie. novel&#xD;
           imaging markers)&#xD;
&#xD;
        -  Correlation of clinical management (neurosurgical treatment vs. best medical care) and&#xD;
           changes in brain blood flow.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">January 1, 2021</start_date>
  <completion_date type="Anticipated">November 1, 2027</completion_date>
  <primary_completion_date type="Anticipated">November 1, 2025</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>• Longitudinal observation of brain blood flow changes in neurosurgical patients with or without a neurosurgical intervention as compared to a healthy cohort.</measure>
    <time_frame>5 years</time_frame>
    <description>blood flow changes will be assessed with quantitative blood oxygenation-level dependent cerebrovascular reactivity measurements</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">400</enrollment>
  <condition>Brain Blood Flow Impairment</condition>
  <arm_group>
    <arm_group_label>Neurosurgical patients</arm_group_label>
    <description>• Neurosurgical diseases with the potential to alter blood flow to the brain:&#xD;
Cerebrovascular disease&#xD;
Brain tumors&#xD;
Normal Pressure Hydrocephalus</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy subjects</arm_group_label>
    <description>Male and Female subjects &gt;18 years of age&#xD;
Written Informed Consent by the participant after information about the project. Foreign speaking healthy subjects should be accompanied by a person with sufficient German language proficiency to act as a translator</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Advanced imaging investigation</intervention_name>
    <description>MRI imaging</description>
    <arm_group_label>Healthy subjects</arm_group_label>
    <arm_group_label>Neurosurgical patients</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Neurosurgical patients with the potential to have altered blood flow to the brain&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion criteria&#xD;
&#xD;
        Patients:&#xD;
&#xD;
          -  Male and Female subjects &gt;18 years of age&#xD;
&#xD;
          -  Written informed consent after participants' information. Foreign speaking patients&#xD;
             should be accompanied by a person with sufficient German language proficiency to act&#xD;
             as a translator&#xD;
&#xD;
          -  Neurosurgical diseases with the potential to alter blood flow to the brain:&#xD;
&#xD;
               -  Cerebrovascular disease&#xD;
&#xD;
               -  Brain tumors&#xD;
&#xD;
               -  Normal Pressure Hydrocephalus&#xD;
&#xD;
        Healthy subjects:&#xD;
&#xD;
          -  Male and Female subjects &gt;18 years of age&#xD;
&#xD;
          -  Written Informed Consent by the participant after information about the project.&#xD;
             Foreign speaking healthy subjects should be accompanied by a person with sufficient&#xD;
             German language proficiency to act as a translator&#xD;
&#xD;
        Exclusion criteria:&#xD;
&#xD;
        Patients:&#xD;
&#xD;
          -  Unwilling or unable to co-operate with breathing maneuvers&#xD;
&#xD;
          -  Respiratory or cardiac limitations to breathing through a mask&#xD;
&#xD;
          -  Medical contra-indications to limited hypercapnia (high CO2 - 50 mmHg) or hypocapnia&#xD;
             (low CO2 - 30 mmHg) (i.e., known increased intracerebral pressure, metabolic acidosis&#xD;
             or alkalosis)&#xD;
&#xD;
          -  Standard contraindications for MRI scanning&#xD;
&#xD;
          -  Verbal confirmed pregnancy&#xD;
&#xD;
          -  Known multiple intracranial diseases&#xD;
&#xD;
          -  Presence of intracranial hemorrhage within the last 3 months&#xD;
&#xD;
          -  Symptomatic increased intracranial pressure&#xD;
&#xD;
        Healthy subjects:&#xD;
&#xD;
          -  Unwilling or unable to co-operate with breathing maneuvers&#xD;
&#xD;
          -  Respiratory or cardiac limitations to breathing through a mask&#xD;
&#xD;
          -  Medical contra-indications to limited hypercapnia (high CO2 - 50 mmHg) or hypocapnia&#xD;
             (low CO2 - 30 mmHg) (i.e., known increased intracerebral pressure, metabolic acidosis&#xD;
             or alkalosis)&#xD;
&#xD;
          -  Standard contraindications for MRI scanning&#xD;
&#xD;
          -  Verbal confirmed pregnancy&#xD;
&#xD;
          -  Anamnesticly a history of neurological disease or current neurological deficits.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Jorn Fierstra, MD, PhD</last_name>
    <phone>0041 442553169</phone>
    <email>jorn.fierstra@usz.ch</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Luca Regli, Professor</last_name>
    <phone>0041442552992</phone>
    <email>Luca.regli@usz.ch</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University Hospital Zurich</name>
      <address>
        <city>Zurich</city>
        <zip>8032</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>December 8, 2020</study_first_submitted>
  <study_first_submitted_qc>December 8, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 16, 2020</study_first_posted>
  <last_update_submitted>December 28, 2020</last_update_submitted>
  <last_update_submitted_qc>December 28, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 29, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

